PetMed Express Inc Net Assets
PetMed Express Inc net assets. Based on the latest financial reports, PetMed Express Inc (PETS) has net assets worth $28.94 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($81.19 Million) and total liabilities ($52.25 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore PetMed Express Inc (PETS) net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $28.94 Million |
| % of Total Assets | 35.64% |
| Annual Growth Rate | 11.7% |
| 5-Year Change | -79.52% |
| 10-Year Change | -65.21% |
| Growth Volatility | 64.69 |
Net Assets of PetMed Express Inc (2000–2026)
Net assets of PetMed Express Inc from 2000 to 2026. This chart illustrates how PetMed Express Inc's net assets have evolved over time, based on quarterly financial data. See net asset quality index of PetMed Express Inc to measure how much of total assets are equity-financed.
Annual Net Assets for PetMed Express Inc (2000–2026)
The table below shows the annual net assets of PetMed Express Inc from 2000 to 2026. For live market cap and overall valuation, see PetMed Express Inc (PETS) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | $28.94 Million | -70.08% |
| 2024-03-31 | $96.73 Million | -12.04% |
| 2023-03-31 | $109.97 Million | -22.66% |
| 2022-03-31 | $142.19 Million | +0.64% |
| 2021-03-31 | $141.28 Million | +8.67% |
| 2020-03-31 | $130.01 Million | -3.47% |
| 2019-03-31 | $134.68 Million | +16.37% |
| 2018-03-31 | $115.73 Million | +23.95% |
| 2017-03-31 | $93.37 Million | +12.23% |
| 2016-03-31 | $83.19 Million | +10.29% |
| 2015-03-31 | $75.44 Million | +7.43% |
| 2014-03-31 | $70.22 Million | +9.69% |
| 2013-03-31 | $64.01 Million | -21.15% |
| 2012-03-31 | $81.18 Million | -16.31% |
| 2011-03-31 | $97.00 Million | +0.15% |
| 2010-03-31 | $96.86 Million | +29.20% |
| 2009-03-31 | $74.97 Million | +11.84% |
| 2008-03-31 | $67.03 Million | +24.45% |
| 2007-03-31 | $53.86 Million | +43.10% |
| 2006-03-31 | $37.64 Million | +55.43% |
| 2005-03-31 | $24.22 Million | +73.05% |
| 2004-03-31 | $13.99 Million | +150.23% |
| 2003-03-31 | $5.59 Million | +253.36% |
| 2002-03-31 | $1.58 Million | +109.00% |
| 2001-03-31 | $757.29K | -53.56% |
| 2000-03-31 | $1.63 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to PetMed Express Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1223314900.0% over the analyzed period, indicating profitable operations and earnings retention.
PetMed Express Inc Net Assets Breakdown (March 2026)
PetMed Express Inc net assets breakdown by equity component as of March 2026.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $9.26 Million | 32.01% |
| Common Stock | $21.00K | 0.07% |
| Other Components | $19.66 Million | 67.92% |
| Total Equity | $28.94 Million | 100.00% |
PetMed Express Inc Competitors by Market Cap
The table below lists competitors of PetMed Express Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Haatz Inc
KQ:066130
|
$25.44 Million |
|
Catena Media plc
ST:CTM
|
$25.44 Million |
|
Dalaroo Metals Ltd
AU:DAL
|
$25.45 Million |
|
Amanah Leasing Public Company Limited
BK:AMANAH
|
$25.47 Million |
|
Eupe Corporation Bhd
KLSE:6815
|
$25.43 Million |
|
Kyobo 8 Special Purpose Acquisition Company
KQ:307280
|
$25.42 Million |
|
ENPlus Co Ltd
KO:074610
|
$25.41 Million |
|
Compania Introductora de Buenos Aires SA
BA:INTR
|
$25.41 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PetMed Express Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2026, total equity changed from 96,731,000 to 28,940,000, a change of -67,791,000 (-70.1%).
- Net loss of 57,286,000 reduced equity.
- Dividend payments of 21,000 reduced retained earnings.
- Other factors decreased equity by 10,484,000.
Equity Change Factors (2024 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-57.29 Million | -197.95% |
| Dividends Paid | $21.00K | -0.07% |
| Other Changes | $-10.48 Million | -36.23% |
| Total Change | $- | -70.08% |
Book Value vs Market Value Analysis
This analysis compares PetMed Express Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.86x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 4.65x to 0.86x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-03-31 | $0.26 | $1.19 | x |
| 2001-03-31 | $0.08 | $1.19 | x |
| 2002-03-31 | $0.08 | $1.19 | x |
| 2003-03-31 | $0.27 | $1.19 | x |
| 2004-03-31 | $0.59 | $1.19 | x |
| 2005-03-31 | $1.02 | $1.19 | x |
| 2006-03-31 | $1.55 | $1.19 | x |
| 2007-03-31 | $2.22 | $1.19 | x |
| 2008-03-31 | $2.76 | $1.19 | x |
| 2009-03-31 | $3.19 | $1.19 | x |
| 2010-03-31 | $4.26 | $1.19 | x |
| 2011-03-31 | $4.28 | $1.19 | x |
| 2012-03-31 | $3.92 | $1.19 | x |
| 2013-03-31 | $3.19 | $1.19 | x |
| 2014-03-31 | $3.50 | $1.19 | x |
| 2015-03-31 | $3.75 | $1.19 | x |
| 2016-03-31 | $4.11 | $1.19 | x |
| 2017-03-31 | $4.58 | $1.19 | x |
| 2018-03-31 | $5.66 | $1.19 | x |
| 2019-03-31 | $6.57 | $1.19 | x |
| 2020-03-31 | $6.48 | $1.19 | x |
| 2021-03-31 | $7.02 | $1.19 | x |
| 2022-03-31 | $6.98 | $1.19 | x |
| 2023-03-31 | $5.41 | $1.19 | x |
| 2024-03-31 | $4.74 | $1.19 | x |
| 2026-03-31 | $1.38 | $1.19 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PetMed Express Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -197.95%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -32.00%
- • Asset Turnover: 2.20x
- • Equity Multiplier: 2.81x
- Recent ROE (-197.95%) is below the historical average (-2.82%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | -110.02% | -12.22% | 2.32x | 3.88x | $-1.96 Million |
| 2001 | -373.27% | -28.25% | 2.22x | 5.95x | $-2.90 Million |
| 2002 | 52.15% | 2.58% | 6.88x | 2.94x | $667.14K |
| 2003 | 58.25% | 5.93% | 6.09x | 1.61x | $2.70 Million |
| 2004 | 41.54% | 6.19% | 5.09x | 1.32x | $4.41 Million |
| 2005 | 33.08% | 7.39% | 3.85x | 1.16x | $5.59 Million |
| 2006 | 32.05% | 8.77% | 3.23x | 1.13x | $8.30 Million |
| 2007 | 26.81% | 8.90% | 2.65x | 1.14x | $9.06 Million |
| 2008 | 29.87% | 10.63% | 2.56x | 1.10x | $13.32 Million |
| 2009 | 30.65% | 10.47% | 2.68x | 1.09x | $15.48 Million |
| 2010 | 26.85% | 10.91% | 2.29x | 1.08x | $16.32 Million |
| 2011 | 21.52% | 9.01% | 2.18x | 1.10x | $11.17 Million |
| 2012 | 20.52% | 6.99% | 2.62x | 1.12x | $8.54 Million |
| 2013 | 26.81% | 7.53% | 3.11x | 1.14x | $10.76 Million |
| 2014 | 25.59% | 7.70% | 2.98x | 1.12x | $10.95 Million |
| 2015 | 23.14% | 7.61% | 2.77x | 1.10x | $9.91 Million |
| 2016 | 24.72% | 8.76% | 2.60x | 1.09x | $12.25 Million |
| 2017 | 25.51% | 9.56% | 2.21x | 1.21x | $14.48 Million |
| 2018 | 32.22% | 13.62% | 2.03x | 1.17x | $25.71 Million |
| 2019 | 28.02% | 13.32% | 1.84x | 1.15x | $24.27 Million |
| 2020 | 19.88% | 9.10% | 1.83x | 1.19x | $12.85 Million |
| 2021 | 16.93% | 7.88% | 1.62x | 1.33x | $9.79 Million |
| 2022 | 14.84% | 7.72% | 1.55x | 1.24x | $6.88 Million |
| 2023 | 4.67% | 2.00% | 1.51x | 1.55x | $-5.86 Million |
| 2024 | -7.72% | -2.72% | 1.61x | 1.76x | $-17.14 Million |
| 2026 | -197.95% | -32.00% | 2.20x | 2.81x | $-60.18 Million |
Industry Comparison
This section compares PetMed Express Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $2,923,639,706
- Average return on equity (ROE) among peers: -114.26%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PetMed Express Inc (PETS) | $28.94 Million | -110.02% | 1.81x | $25.43 Million |
| Bimi International Medical Inc (BIMI) | $5.22 Million | -429.21% | 5.85x | $6.98K |
| High Tide Inc (HITI) | $-9.66 Million | 0.00% | 0.00x | $204.80 Million |
| Trxade Group Inc (MEDS) | $267.02K | -418.39% | 6.59x | $3.36 Million |
| POMDOCTOR LIMITED American Depositary Shares (POM) | $-481.30 Million | 0.00% | 0.00x | $6.77 Million |
| Ridgetech, Inc. (RDGT) | $18.86 Million | -90.44% | 2.91x | $2.91 Million |
| Scienture Holdings, Inc. (SCNX) | $-18.51K | 0.00% | 0.00x | $15.07 Million |
| SunLink Health Systems Inc (SSY) | $33.74 Million | 13.30% | 1.02x | $7.85 Million |
| Walgreens Boots Alliance Inc (WBA) | $23.82 Billion | 10.67% | 2.41x | $10.37 Billion |
About PetMed Express Inc
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional suppleme… Read more